These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial]. Zhang X, Zhang HT, Lyu Y, Wang LF, Yang ZY. Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509 [Abstract] [Full Text] [Related]
7. Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants. Puia-Dumitrescu M, Smith PB, Zhao J, Soriano A, Payne EH, Harper B, Bendel-Stenzel E, Moya F, Chhabra R, Ku L, Laughon M, Wade KC, Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. J Pediatr; 2019 Aug; 211():27-32.e1. PubMed ID: 31101409 [Abstract] [Full Text] [Related]
10. [Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial]. He T, Liao ZC, Ding Y, Wang MJ, Li W, Gan JM, Yue SJ. Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):684-689. PubMed ID: 32669161 [Abstract] [Full Text] [Related]
12. The timing of withdrawal from caffeine citrate in very preterm infants. Zhang XF, He XR, Li W, Wang T, Hu JT, Dong QY, Chen PY. Zhongguo Dang Dai Er Ke Za Zhi; 2021 Dec 15; 23(12):1228-1233. PubMed ID: 34911605 [Abstract] [Full Text] [Related]
14. Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial. Elmowafi M, Mohsen N, Nour I, Nasef N. J Matern Fetal Neonatal Med; 2022 Dec 15; 35(25):6053-6061. PubMed ID: 33771081 [Abstract] [Full Text] [Related]
15. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Stevens TP, Blennow M, Soll RF. Cochrane Database Syst Rev; 2002 Dec 15; (2):CD003063. PubMed ID: 12076469 [Abstract] [Full Text] [Related]
16. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants. He X, Qiu JC, Lu KY, Guo HL, Li L, Jia WW, Ni MM, Liu Y, Xu J, Chen F, Cheng R. Adv Ther; 2021 Jan 15; 38(1):607-626. PubMed ID: 33180318 [Abstract] [Full Text] [Related]
17. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study. Lista G, Fabbri L, Polackova R, Kiechl-Kohlendorfer U, Papagaroufalis K, Saenz P, Ferrari F, Lasagna G, Carnielli VP, Peyona® PASS Group. Neonatology; 2016 Jan 15; 109(3):221-7. PubMed ID: 26820884 [Abstract] [Full Text] [Related]
18. [Effect of caffeine citrate on early pulmonary function in preterm infants with apnea]. Yu M, Huang JH, Zhu R, Zhang XZ, Wu WY, Wen XH. Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar 15; 18(3):206-10. PubMed ID: 26975815 [Abstract] [Full Text] [Related]
19. [Short-term outcomes and their related risk factors of extremely preterm and extremely low birth weight infants in Guangdong province]. Collaborative Study Group for Extremely Preterm and Extremely Low Birth Weight Infants. Zhonghua Er Ke Za Zhi; 2019 Dec 02; 57(12):934-942. PubMed ID: 31795560 [Abstract] [Full Text] [Related]